conversion of papillomas of higher probability of malignant USA conversion to SCCs. The results of this study suggest that 1 To whom correspondence should be addressed irrespective of the risk involved, GTP may be highly useful We earlier showed that a polyphenolic fraction isolated in affording protection against skin cancer risk. from green tea (GTP) affords protection against tumor promotion and tumor progression in SENCAR mouse skin. The present study was designed to further evaluate the Introduction protective effect of GTP against the induction and subsequent progression of papillomas to squamous cell carcinMultistage models of carcinogenesis have been developed for omas (SCCs) in experimental protocols where papillomas various tissues and animal species for mechanistic studies. were developed with a low or high probability of their These animal models also play an important role as in vivo test malignant conversion. Topical application of GTP (6 mg/ systems in the identification of exogenous and/or endogenous animal) 30 min prior to that of 12-O-tetradecanoylphorbolagents playing a role in enhancement and prevention of 13-acetate (TPA) either once a week for 5 weeks (high risk various stages of carcinogenesis. In this context the initiation-TPA protocol) or once a week for 20 weeks (low risk TPA promotion protocol of mouse skin carcinogenesis has been protocol) or mezerein (MEZ) twice a week for 20 weeks widely used both for studies on mechanisms involved in (high risk MEZ protocol) in 7,12-dimethylbenz[a]anthrachemical carcinogenesis and for testing of carcinogenic or cene (DMBA)-initiated mouse skin resulted in significant anti-carcinogenic agents (1-3). protection against skin tumor promotion in terms of tumor
Introduction protective effect of GTP against the induction and subsequent progression of papillomas to squamous cell carcin-
Multistage models of carcinogenesis have been developed for omas (SCCs) in experimental protocols where papillomas various tissues and animal species for mechanistic studies. were developed with a low or high probability of their These animal models also play an important role as in vivo test malignant conversion. Topical application of GTP (6 mg/ systems in the identification of exogenous and/or endogenous animal) 30 min prior to that of 12-O-tetradecanoylphorbolagents playing a role in enhancement and prevention of 13-acetate (TPA) either once a week for 5 weeks (high risk various stages of carcinogenesis. In this context the initiation-TPA protocol) or once a week for 20 weeks (low risk TPA promotion protocol of mouse skin carcinogenesis has been protocol) or mezerein (MEZ) twice a week for 20 weeks widely used both for studies on mechanisms involved in (high risk MEZ protocol) in 7,12-dimethylbenz[a]anthrachemical carcinogenesis and for testing of carcinogenic or cene (DMBA)-initiated mouse skin resulted in significant anti-carcinogenic agents (1-3).
protection against skin tumor promotion in terms of tumor
In the mouse skin the process of carcinoma formation has incidence (32-60%), multiplicity (49-63%) and tumor volbeen subdivided into at least three operationally defined ume/mouse (73-90%) at the termination of the experiment stages: initiation, promotion and malignant progression (2, 3) . at 20 weeks. In three separate malignant progression
Collective information from numerous studies using the initiexperiments when papilloma yield in DMBA-initiated and ation-promotion model of skin carcinogenesis suggests a TPA or MEZ promoted low and high risk protocols was sequence of events starting from an initiated cell, passing stabilized at 20 weeks, animals were divided into two through a benign papilloma stage and finally leading to the subgroups. These animals were either topically treated development of carcinomas (4) . Initiation can be brought twice weekly with acetone (0.2 ml/animal, spontaneous about by a single topical application of a subcarcinogenic dose malignant conversion group) or with GTP (6 mg/animal in of a carcinogen, such as 7,12-dimethylbenz[a]anthracene 0.2 ml acetone) for an additional period of 31 weeks.
(DMBA*). Initiation causes a permanent genetic alteration in During these treatment regimens, all suspected carcinomas some epidermal cells (initiated cells), which give rise to were recorded and each one was verified histopathologicepidermal tumors only upon subsequent promotion. Promotion ally either at the time when tumor-bearing mouse died/ of the DMBA-initiated skin to generate benign tumors (papilmoribund or at the termination of the experiment at 51 lomas) is accomplished by repeated topical applications of a weeks. GTP resulted in significant protection against the promoting agent, such as the phorbol ester 12-O-tetradecanoylmalignant conversion of papillomas to SCC in all the phorbol-13-acetate (TPA). Carcinoma formation apparently protocols employed. At the termination of the experiment does not occur in initiated skin without promotion, indicating at 51 weeks, these protective effects were evident in terms that the latter is a prerequisite for malignant progression, i.e. of mice with carcinomas (35-41%), carcinomas per mouse carcinomas usually develop from papillomas, but in some (47-55%) and percent malignant conversion of papillomas other skin tumor protocols many carcinomas do not first go to carcinomas (47-58%). The kinetics of malignant converthrough the papilloma stage (4, 5) . However, such a view is sion suggest that a subset of papillomas formed in the early complicated by the observation of a substantial heterogeneity phase of tumor promotion in all the protocols had a higher among papillomas (reviewed in 5). Many papillomas have probability of malignant conversion into SCCs because all been found to require continued exposure to TPA in order to the positive control groups (acetone treated) produced prevent regression (6-9), whereas some regress even in the nearly the same number of carcinomas (33-38 in a group presence of the promoter (9) . A certain percentage of papillomas has been shown to persist for the lifetime of the TPA-induced skin tumor promotion in DMBA-initiated SENgroups. In these mice, tumors were induced by the topical application of tumor promoters in DMBA-initiated SENCAR mice using the same protocols CAR mouse skin (13) (14) (15) . In addition, we have shown that described for Groups IA, IIA and IIIA. In brief, Group I will develop topical application of GTP also affords protection against papillomas with low probability of conversion into SCC, while Groups II and spontaneous malignant conversion as well as against malignant III will develop papillomas with a higher probability of conversion into SCC.
conversion enhanced by the free radical-generating compound To gain further knowledge about the anticarcinogenic effects study at the start of this experiment, i.e. at 20 weeks. These 40 mice were of GTP, in the present study experimental protocols were divided into two subgroups of 20 mice in each. In each of the three protocols, adopted to elicit papillomas with a lower as well as higher mice in the first subgroup were treated twice weekly with acetone (0.2 ml/ mouse), whereas in the second subgroup they were treated twice weekly with probability of malignant conversion in mouse skin (17, 18) .
GTP (6 mg/mouse in 0.2 ml acetone). These treatments were continued up to
Thus the aim of our study was to evaluate the chemopreventive the end of the experiment at week 51 (31 weeks after promoter treatment).
efficacy of GTP among a heterogenous population of papilCarcinomas formed on each mouse during these treatment protocols were lomas with variable risk of cancer induction. By using three counted grossly as downward invading lesions per week and each one was different protocols of the mouse skin multistage chemical verified histopathologically at the time of termination of the experiment at week 51 as described earlier (17, 18) . In addition, when carcinoma-bearing carcinogenesis model, the effect of GTP was assessed against mice were moribund, they were killed and all tumors were harvested for tumor promotion as well as subsequent progression of papil- Tumor tissue, from papilloma-bearing or suspected carcinoma-bearing mice, WI). GTP was prepared from green tea leaves as described earlier and is a for histological evaluation was prepared using conventional paraffin sections mixture of four epicatechin derivatives, namely (-)-epicatechin, (-)-epicatechin and hematoxylin and eosin staining. Histology was performed for all the 3-gallate, (-)-epigallocatechin and (-)-epigallocatechin 3-gallate (19). All tumors at week 20, i.e. at the end of the tumor promotion experiment, and in other chemicals were of the highest quality commercially available.
week 51 of the progression experiment. SCCs were diagnosed microscopically as downward invading lesions. Animals Six-seven week old female SENCAR mice, obtained from Harlan-Sprague Statistical analysis Dawley (Indianapolis, IN), were acclimatized for 1 week before use and
The statistical significance of differences between positive controls and GTPsubjected to a 12 h light/12 h dark cycle, housed at 24 Ϯ 2°C and 50 Ϯ 10% treated experimental groups in terms of papilloma and carcinoma incidence relative humidity in a room with 12-15 cycles of air exchange/h and fed and multiplicity was evaluated by χ 2 analysis and the Wilcoxon rank sum test. Purina chow diet and water ad libitum.
Induction of papillomas in SENCAR mouse skin

Results
One week after their arrival, the dorsal skin of the mice was shaved using
Effect of GTP on tumor promotion
electric clippers and then Nair depilatory cream was applied. Only those mice which were in the resting phase of their hair cycle were used in this study.
In previous studies we and others (13) (14) (15) have shown that
The details of tumor protocols employed are those described earlier (17, 18) . topical applications of GTP before each application of TPA In brief, mice were divided into three groups termed Groups I, II and III (40 affords substantial protection against tumor formation in mice in each) and treated topically on the shaved area with a single application DMBA-initiated SENCAR mouse skin in a dose-dependent of DMBA (20 µg/mouse in 0.2 ml acetone). One week later, mice in all three groups were subdivided randomly into two subgroups, A and B. The animals manner. In the present study we modulated the development in Group 1A were treated topically once a week with TPA (2 µg/mouse in of the number of papillomas per mouse by adopting three 0.2 ml acetone) for 20 weeks, designated the 'low risk TPA protocol' (LRdifferent protocols (17) which have a high or low probability TPA). In this protocol the papillomas which develop are known to have a low for conversion into carcinomas. Topical applications of GTP probability of conversion to carcinomas (17, 18) . The mice in Group 1B were prior to each application of the tumor promoters in DMBAtopically treated with GTP (6 mg/mouse in 0.2 ml acetone) 30 min before each TPA application as in Group 1A. The animals in Group IIA were initiated SENCAR mice resulted in a significant protection topically treated once a week with TPA (2 µg/mouse in 0.2 ml acetone) for against tumor promotion in each of the low and high risk 5 weeks and then were left for an additional 15 weeks, designated the 'high protocols employed. The protective effect of GTP was evident risk TPA protocol' (HR-TPA). In this protocol the papillomas which develop in terms of tumor incidence and tumor multiplicity as well as have a high probability of conversion to carcinomas (17, 18) . The mice in Group IIB were topically treated with GTP (6 mg/mouse in 0.2 ml acetone) size of the tumor. As shown by the data in Figure 1 One novel aspect of these studies was the modulation of the Figure 1 also shows the kinetics of papilloma formation in number of papillomas generated per mouse by adopting three groups of SENCAR mice receiving respectively TPA applicadifferent protocols as described in Materials and methods. Two tion for only 5 weeks (high risk of malignant conversion into high risk tumor protocols also allowed us to examine, under SCC) or continued promotion with MEZ for up to 20 weeks conditions of relatively low tumor burden, the protective (high risk of malignant conversion into SCC). Compared with effects of GTP against progression of papillomas to carcinomas the LR-TPA protocol showing 95% mice with papillomas, the in mouse skin. Similarly to anti-skin tumor promoting effects, HR-TPA and HR-MEZ protocols generated papillomas in only GTP also afforded significant protection against the malignant 50 and 85% of mice respectively at the end of week 20.
conversion of chemically induced papillomas to SCC in all However, pre-application of GTP to that of either TPA or the employed protocols of this study. The protective effect of MEZ resulted in 20 or 35% of mice with tumors respectively GTP was evident in terms of carcinoma incidence, carcinoma in the HR-TPA and HR-MEZ protocols, which indicated multiplicity and percent malignant conversion of papillomas significant protection by GTP. In terms of tumor incidence the to SCCs. protection was 60% (P Ͻ 0.005, χ 2 test). In terms of tumor
The malignant conversion of papillomas to SCC in the LRmultiplicity, a significant variation was observed among differ-TPA protocol is shown in Figure 3 (left panel). Treatment ent protocols, as shown in Figure 1 observed. In terms of carcinoma multiplicity ( Figure 3 , left respectively were observed. At termination of the experiment, bottom panel), GTP treatment resulted in 47% protection (P in comparison with non-GTP-treated animals, pre-application Ͻ 0.01, Wilcoxon rank sum test) in comparison with the of GTP to that of the tumor promoters resulted in 42 and 63% acetone-treated control group (spontaneous malignant converinhibition (P Ͻ 0.01 and 0.005, Wilcoxon rank sum test) in sion group) of animals. tumor multiplicity in high risk-associated papillomas respectSimilarly to the LR-TPA protocol, treatment with GTP ively in the TPA-and MEZ-treated groups of animals. also resulted in significant protection against spontaneous When these tumor data were considered in terms of total tumor volume per mouse at the termination of the experiment conversion of papillomas to SCC throughout the experiment tumors is in the order HR-TPA Ͼ HR-MEZ Ͼ LR-TPA ( Figure  4 ). It is apparent from the data shown in Figure 4 that application of GTP afforded a significant reduction in the percent malignant conversion of papillomas into SCC in the LR-TPA, HR-TPA and HR-MEZ groups respectively (47, 48 and 58%, P Ͻ 0.03-0.01, Mantel-Haenszel χ 2 test) at the termination of the experiment at 51 weeks. Remarkably, larger SCC developed in the HR-TPA group in comparison with the LR-TPA and HR-MEZ groups. This may be because of fewer numbers of tumors on the backs of each animal, which provided more space for carcinoma development. It is important to mention here that no additional tumors appeared in any mice between 20 and 51 weeks on test.
Prevention kinetics of GTP against malignant conversion
At the termination of the experiment at 51 weeks, the ultimate number of carcinomas formed in a group of 20 mice in the spontaneous malignant conversion subgroups of the LR-TPA, HR-TPA and HR-MEZ protocols ranged between 33 and 38. This shows that a subset of papillomas formed in the early phase is possibly highly charged with the probability of conversion into SCC. Continuous treatment with either TPA, as in the low risk tumor protocol ( Figure 1, left panel) , or MEZ, as in the high risk tumor protocol ( Figure 1 , right panel), although producing a greater number of papillomas per mouse, were not associated with a higher risk of malignant conversion. This information led to the suggestion that different subsets of papillomas exist with different probabilities of malignant conversion and that many papillomas are not associated with a risk of progression to SCC. This study also provides information that only limited treatment with TPA (5 weeks) carcinomas). An analysis of these data also reveals that the maximum percentage (87%) of papillomas was converted to on the HR-TPA protocol, as shown in Figure 3 (middle panel) .
SCC in the HR-TPA group, while 55 and 19% papillomas At the end of the experiment at 51 weeks, treatment with GTP were converted to SCC respectively in the HR-MEZ and LRresulted in 40% protection (P Ͻ 0.01, χ 2 analysis) in terms of TPA groups. Additional analysis of the data showed that the percentage of mice with carcinomas ( Figure 3 , middle top application of GTP afforded 47, 48 and 58% protection against panel), while 49% (P Ͻ 0.03, Wilcoxon rank sum test) spontaneous malignant conversion respectively in the LR-TPA, protection was observed in terms of number of carcinomas and HR-TPA and HR-MEZ groups of animals. per mouse (Figure 3 , middle bottom panel). As shown in Figure 3 (right panel), treatment with GTP also resulted in Discussion protection against malignant conversion of papillomas to SCC in the HR-MEZ protocol throughout the experiment in The mouse skin model of multistage carcinogenesis provides an experimental framework to study basic mechanisms associated comparison with the acetone-treated positive control group (spontaneous malignant conversion group) of animals. At the with the initiation, promotion and progression stages. This model has also proved useful in identifying cancer chemoprevend of the experiment at 51 weeks, GTP treatment resulted in 35% protection (P Ͻ 0.02, χ 2 analysis) in terms of the entive agents. In several studies we and others have shown the chemopreventive effect of GTP in the mouse skin chemical percentage of mice with carcinomas ( Figure 3 , right top panel), while 55% protection (P Ͻ 0.01, Wilcoxon rank sum test) carcinogenesis model system (13) (14) (15) 21) . These preventive effects appear to be a consequence of anti-inflammatory was evident in terms of number of carcinomas per mouse (Figure 3, right bottom panel) .
and/or anti-oxidant properties of GTP (13, 15, (22) (23) (24) . The administration of GTP or its components either topically or The percent malignant conversion of chemically induced papillomas was computed at different time intervals during through drinking water to mice has been shown to reduce both the occurrence and the growth of tumors induced chemically the progression period in the acetone-treated spontaneous group as well as in the GTP-treated group, which clearly or by UVB radiation (25, 26) . Katiyar et al. (16) have also shown that GTP protects against malignant conversion of indicates that application of GTP afforded protection against malignant conversion of papillomas to SCC throughout the chemically induced benign skin papillomas to SCC in SEN-CAR mice. experimental period (data not shown). At the end of the experiment at 51 weeks, we summarized the percent malignant
In this study different tumor promotion protocols were employed to elicit papillomas with a low as well as high conversion in each of the groups. These data showed that the rate of percent malignant conversion of the non-malignant probability of malignant conversion to further test the efficacy Protection by green tea against malignant conversion enhancement of expression of the pro-inflammatory cytokine IL-1α (28) . In the case of protection against malignant conversion by GTP, the mechanism, although not clear, may be related to its anti-oxidant properties. Earlier we showed that GTP and its individual epicatechin components inhibit spontaneous lipid peroxidation (23) in mouse epidermal microsomes, which may also be an important factor in reducing free radical generation in mouse skin and hence in inhibition of tumor promotion as well as conversion of papillomas to SCC. In our previous study we also showed that GTP inhibits malignant conversion enhanced by the free radical-generating compound benzoyl peroxide (16) . It has been demonstrated that application of DMBA and TPA to mouse skin results in depletion of Langerhans cells (LC), an important event associated with the pathogenesis of skin cancer (29, 30) . This depletion of LC from the epidermis (29, 30) may provide an appropriate microenvironment for the be important because it provides evidence that depletion of LC from the skin is a crucial part of the tumor promotion process (34). In our tumor promotion protocol we utilized of GTP against the development of papillomas and their DMBA as the initiator and TPA as the tumor promoter, both subsequent conversion to SCC. Several laboratories have of which can cause suppression of the immune system through provided evidence for an alternative model whereby initiation-LC depletion in the skin. We have shown that GTP protects promotion regimens generate at least two major classes of against UVB radiation-induced local and systemic suppression papillomas; one with a high probability of progression and a of the contact hypersensitivity response in C3H/HeN mice second with a low probability of progression to SCC (35) . GTP thus may protect against the induction of immune (4, 6, 18, 27) . The results of the present study indicate that in suppression caused by either DMBA or TPA and this may be both cases, whether the tumors have low or high probability the possible mechanism involved in protection against tumor of malignant conversion, pre-application of GTP to that of the promotion and subsequent progression of papillomas to SCCs. tumor promoters is highly effective in reducing the generation
In conclusion, the data in this manuscript indicate that a of papillomas, as well as their subsequent conversion to SCC. much higher proportion of existing papillomas generated with Mechanistic studies regarding the anti-tumor promoting effect high risk-associated standard initiation-promotion protocols of GTP have shown that topical application of GTP prior to using TPA or MEZ as the tumor promoters progress to SCCs that of tumor promoters onto mouse skin inhibits tumor in comparison with low risk-associated papillomas, and in promoter induction of ornithine decarboxylase and cycloboth the cases GTP affords protection against malignant oxygenase-and lipoxygenase-catalyzed metabolism of arachiconversion of papillomas to SCCs. Thus our data suggest that donic acid (13) . Skin application of GTP has also been shown to inhibit TPA-induced epidermal edema, hyperplasia and irrespective of the risk involved in skin carcinogenesis, topical
